Compare
Tilray Brands, Inc. vs USANA Health Sciences Inc vs Trulieve Cannabis Corp. vs Curaleaf Holdings, Inc.
| Latest fiscal year | Tilray Brands, Inc. TLRY | USANA Health Sciences Inc USNA | Trulieve Cannabis Corp. TRLV | Curaleaf Holdings, Inc. CURLF |
|---|---|---|---|---|
| Year ended | 2026-05-31 | 2026-01-03 | 2025-12-31 | 2025-12-31 |
| Revenue | $915.45M | $925.26M | $1.18B | $1.27B |
| Revenue growth (YoY) | +11.5% | +8.3% | -0.4% | -5.0% |
| Gross margin | 28.4% | 78.3% | 60.2% | 49.8% |
| Operating margin | -6.9% | 4.0% | 12.1% | 2.0% |
| Net margin | -13.3% | 1.2% | -10.3% | -18.2% |
| Net income | -$121.40M | $10.76M | -$122.25M | -$231.07M |
| EPS (Diluted) | -$1.09 | $0.58 | -$0.58 | -$0.35 |
| Operating cash flow | -$69.14M | $22.35M | $272.82M | $137.71M |
| Free cash flow | n/a | $8.53M | $228.63M | $74.27M |
| Cash & equivalents | $225.98M | $158.38M | $255.53M | n/a |
| Total assets | $2.33B | $742.91M | $2.70B | $2.85B |
| Total liabilities | $733.14M | $156.64M | $1.55B | $2.01B |
| Shareholders' equity | $1.61B | $533.10M | $1.14B | $756.35M |
| Return on year-end equity | -7.5% | 2.0% | -10.7% | -30.6% |
| Shares outstanding | 131.68M | 18.28M | 192.31M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Tilray Brands, Inc. | USANA Health Sciences Inc | Trulieve Cannabis Corp. | Curaleaf Holdings, Inc. |
|---|---|---|---|---|
| Latest | $915.45M Ended 2026-05-31 | $925.26M Ended 2026-01-03 | $1.18B Ended 2025-12-31 | $1.27B Ended 2025-12-31 |
| 1 year earlier | $821.31M Ended 2025-05-31 | $854.50M Ended 2024-12-28 | $1.19B Ended 2024-12-31 | $1.33B Ended 2024-12-31 |
| 2 years earlier | $788.94M Ended 2024-05-31 | $921.01M Ended 2023-12-30 | $1.13B Ended 2023-12-31 | $1.35B Ended 2023-12-31 |
| 3 years earlier | $627.12M Ended 2023-05-31 | $998.60M Ended 2022-12-31 | $1.22B Ended 2022-12-31 | $1.28B Ended 2022-12-31 |
| 4 years earlier | $628.37M Ended 2022-05-31 | $1.19B Ended 2022-01-01 | $931.93M Ended 2021-12-31 | $1.20B Ended 2021-12-31 |